ARTICLES BY BARBARA LOPEZ KUNZ
-
![Trial Return On Engagement: Quantifying Benefits Of Patient-Centric Initiatives]( "Trial Return On Engagement: Quantifying Benefits Of Patient-Centric Initiatives")
Trial Return On Engagement: Quantifying Benefits Of Patient-Centric Initiatives6/27/2017Return on investment (ROI) is a key metric for business performance, and well-functioning organizations typically bring their stakeholders high ROI. The “return on” concept can also be applied in measuring how well organizations engage with their customers.
Barbara Lopez Kunz
Barbara Lopez Kunz, M.S., is global chief executive of DIA. She is leading the transformation of DIA through developing and implementing a strategy that focuses on engaging the global healthcare community in DIA’s neutral platform, to drive thought leadership and innovation in the development of therapeutics to improve the health of people worldwide.